Abstract
Objective
To make an informed viewpoint on the usefulness of Tuberculin Skin test (TST) compared to Interferon Gamma Release Assays (IGRAs) for diagnosis of Latent TB Infection (LTBI) in different geographical settings.
Methods
We reviewed the current literature on TST compared to IGRA, including national implementation of WHO LTBI recommendations and retrospective data over the past 7 years at the National Institute for Infectious Diseases “L. Spallanzani” as indirect indicator of usage of both tests under actual programmatic conditions.
Results
Current national guidelines vary considerably, reflecting the uncertainty and rapidly evolving evidence about the potential use of these tests. Data from Institute “L. Spallanzani” showed IGRA concordance in TST positive subjects only in 54.74% of subjects, while there was strong concordance between two tests in TST negative subjects (93.78%).
Conclusion
Neither IGRAs nor TST can distinguish active TB from LTBI. TST will continue to be clinically useful in low and high TB endemic areas until more accurate and predictive tests will become available. Clinical judgment remains fundamental in choosing between IGRA/TST tests and interpreting their results
| Original language | English |
|---|---|
| Pages (from-to) | S20-S22 |
| Journal | International Journal of Infectious Diseases |
| Volume | 80 |
| Early online date | 6 Feb 2019 |
| DOIs | |
| Publication status | Published - 1 Mar 2019 |
Keywords
- IGRA
- Interferon-γ release assays
- Latent TB
- LTBI
- Quantiferon
- TB
- TST
- Tuberculin skin test
- Tuberculosis
